Abstract
Detection of the tipping point of metastasis of non-small cell lung carcinoma is crucial so that it does not lead to irreversible damage. In contrast to the single biomarker approach, identification of dynamic network biomarkers (DNB) which represent the dynamic change in the expression during disease progression is being increasingly used to study of tipping point in different cancers. In our study, stage-wise gene expression data from a lung cancer database with in silico dynamic network method revealed AZIN1 centric network of seven dynamically interacting genes (AZIN1, PGAM1, CNOT9, HMGCR, EIF3H, DNTTIP1, and ST7). These are involved in purine ribonucleoside monophosphate and purine ribonucleoside triphosphate metabolic pathways. Drastic changes in their gene expressions were observed at 2A and 2B transition stage indicating it to be a tipping point for metastasis. Further, in vitro gene expression studies in NCI-460 cells confirmed the interaction of networking genes. Silencing AZIN1 expression diminished DNTTIP1 and PGAM1 expression almost completely while significantly affecting other genes; further confirming a novel interaction of these genes in non-small cell lung carcinoma (NSCLC). Therefore, AZIN1 centric network of seven genes could serve as an important predictive DNB for the tipping point before NSCLC metastasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
